Experimental — This treatment is under research. Available data is limited. Consult your doctor before making any decision.
Medication for type 2 diabetes and weight management, investigated in Long COVID for its potential to reduce inflammation and improve metabolic dysfunction.
Information
Subcategory
GIP and GLP-1 receptor agonist
Evidence level
2/5
Evidence type
case series and preclinical rationale
Share your experience
Your feedback helps thousands of people find what really works.